Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Camptoo is a web application by which travellers can rent a motorhome straight from the owner. Its users can easily rent any of the available 3,000+ vehicles offered in fifteen countries. This company turned motorhome ownership into a revenue-making venture instead of an expensive hobby. More than 50,000 users have experienced travelling using Camptoo, and its number is growing year on year. It was part of the Google Launchpad accelerator program in 2015. Furthermore, in the Netherlands, it was awarded 'most promising startup' by Deloitte Technology Fast50 Jury in 2017, and in Europe, '16th fastest growing tech company' by TheNextWeb in 2018. With the proceeds, this company will further accelerate marketing campaigns in Australia and the UK and further optimize its current web application.
days to go:
Expired
investment:
£476,642
Go Zero is an electric taxi service. Since its inception in 2017, the company has completed over 10,000 journeys, saved an estimated 174 tonnes of CO2, and witnessed £530,000 worth of sales. The UK taxi industry is a £9 billion-pound industry and Go Zero, with its fleet of electric taxis powered by 100% renewable energy sources, aims to be a major disruptor. The company has received 100+ 5-star customer reviews and in 2019, it added 1600 new customers to its network. In February 2020, it launched the Go Zero Network, a network of 1,000 electric taxi franchises across the UK to expand electric travel for all. Being a part of the Go Zero Network offers a franchisee the opportunity to purchase a 5-year licence enabling them to operate their own business under the Go Zero brand. It also gives them the potential to earn between £30,000 and £50,000 after costs, based on performance metrics. With the investment, the company aims to recruit a high performing team to deliver market share, focused on sales, digital marketing, social media, franchise recruitment and management.
days to go:
Expired
investment:
£124,530
Moody is a health-tracking application that connects users with customised health, food and fitness advice based on their moods, symptoms and cycles. It endeavours to become a sustainable force for good in women's health. The company argues that women control >80% of household health spend and are 80% more likely than men to use a digital health app. It aims to harness these trends and capitalise on the global remote health care market that is forecast to hit £40 billion by 2025. 'The Moody Month' app featured in publications like Vogue, Grazia and The Guardian. It has witnessed over 136,000 downloads since its Version 1 release in 2019. The app has compiled over 5 million moods to date. The company will use the investment to scale its business globally and reach 1 million subscribers within a four-year time frame.
days to go:
Expired
investment:
£142,026
Riders can enjoy indoor cycling within a boutique fitness studio. In the past 6 years, Boom Cycle have opened five sites are now seeking funds to expand their portfolio. To date, Boom Cycle has acquired over £4.1m from private investors and in 2017 spent £2.1m on developing two flagship studios. The company has experienced attendance growth of 47% YoY, as well as a 77% increase in revenue YoY.
days to go:
Expired
investment:
£805,260
Karshare connects renters with owners, giving those with cars the opportunity to earn extra income while those in need of a car can rent from their local community. The company aims to unlock community car sharing by tapping into the estimated 10 million cars parked at UK airports each year and 38 million vehicles parked on UK streets. Karshare's platform features telematics and keyless technology allowing for cars to be booked instantly and unlocked using facial recognition. Karshare has a TrustScore of 4.9/5 and 852 reviews. It has onboarded partners such as Allianz Insurance, OCTO Telematics, Rentalcars.com, and RAC. Karshare has featured in press publications like The Times, Huff Post, BBC and Evening Standard amongst others. The company will use 25% of the investment for business operations, 45% for growing the business, and 31% for developing User Experience (UX) and functionality.
days to go:
Expired
investment:
£1,444,182
FLY LDN is a fitness brand that imparts sports and fitness instruction via its digital platform and its studios in central London and Fitzrovia. The company launched its video-on-demand and live-streaming fitness platform, FLY LDN Online (FLO), in September 2020. It asserts that within six months of launch, FLO scaled over 28,000 monthly views across 80+ countries with users having viewed over 2.5 million minutes of FLY LDN workouts. FLY LDN won the Men's Health 'Best Studio 2019' award and was commended at the 2018 and 2019 Tatler Gym Awards. The company has also received press coverage in publications like Women's Health, Forbes, Esquire, Elle, Vogue, GQ and Glamour. It has also partnered with brands such as DKNY and ASOS. FLY LDN aspires to become a contender in the global online fitness market that is expected to reach $59 billion by 2027. The company will use the investment to further develop additional functionality and TV apps for FLO and fund marketing campaigns to fuel growth.
days to go:
Expired
investment:
£340,928
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
